Millennium up on data, TV spot

MLNM was up $1.14 (14%) to $9.41 on Friday after two studies of MLN02 and Velcade bortezomib were published in the New England Journal of Medicine on Thursday. Also helping the stock was a feature on CNBC's Mad Money on Thursday evening. MLNM declined to comment on the company's stock move. ...